These findings provide evidence that treatment with ZnCM could attenuate inflammatory response and may be related to the inactivation of the TLR4/NF-κB pathway in Cd-exposed rats with diabetic nephropathy. This evidence concerns the gene TLR4 and diabetic kidney disease.